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ABSTRACT
Objectives While the uptake of value- based health care 
(VBHC) is remarkable, uncertainty prevails regarding the 
most important actions and practices in establishing a 
value- based healthcare system. In this paper, we generate 
expert consensus on the most important aspects of VBHC.
Design The Delphi technique was used to reach 
consensus on the most important practices in moving 
towards a value- based healthcare system.
Setting and participants A Dutch expert panel consisting 
of nine members participated in a two- round survey.
Primary and secondary outcome measures We 
developed 39 initial items based on the pioneering 
literature on VBHC and recent health policies in the 
Netherlands. Experts rated the importance of each item 
on a 4- point Likert scale. Experts could change items or 
add new ones as they saw fit. We retained items that were 
rated (very) important by ≥80% of the panel.
Results After two survey rounds, 32 items (72%) were 
included through expert consensus. Experts unanimously 
agree on the importance of shared decision- making, 
with this item uniquely obtaining the maximum score. 
Experts also reached consensus on the importance of 
outcome measurements, a focus on medical conditions, 
and full cycles of care. No consensus was reached on the 
importance of benchmarking.
Conclusion This paper provides new insight into the most 
important actions and practices for establishing a value- 
based healthcare system in the Netherlands. Interestingly, 
several of our findings contrast with the pioneering 
literature on VBHC. This raises the question whether 
VBHC’s widespread international uptake indicates its 
actual implementation, or rather that the original concept 
primarily serves as an inspiring idea.
INTRODUCTION 
Value- based health care (VBHC) is a highly 
topical concept within many healthcare 
systems.1–3 The concept was pioneered by 
Michael Porter and Elizabeth Teisberg, who 
propose an overarching goal for all stake-
holders in health care: to optimise value for 
patients.4 Thus far, however, it remains rela-
tively unclear how to transition this popular 
idea into the actual establishment of a 
value- based system—despite Porter’s attempts 
to outline just that.4–7
Several studies report fragmented and 
muddled efforts to implement VBHC.8–10 
Some scholars attribute these instances to 
the ‘high level of abstraction’ and ‘vagueness’ 
in which VBHC was originally described.9 
Although we recognise that VBHC is an 
abstract concept, we believe its muddled 
implementation can at least partially be 
explained by its multifaceted composition.
VBHC was developed as a strategy that 
aims to inform all stakeholders in healthcare 
systems.4 It is an extensive concept with far- 
reaching implications: its goal is to ‘transform 
health care’ (p4).4 In a value- based system, 
all stakeholders share a common objective: 
value for patients—with value defined as a 
patient’s health status (outcomes) divided 
by the recourses it took to achieve that status 
(costs). Importantly, Porter and Teisberg 
argue that value can only be understood at 
the level at which it is created: in addressing 
a medical condition, over full cycles of care 
Strengths and limitations of this study
 ► Using the Delphi technique, this study generates ex-
pert consensus on the most important actions and 
practices in moving towards a value- based health-
care system.
 ► By revealing 32 actions and practices, this research 
operationalises value- based health care, a highly 
abstract and multifaceted concept.
 ► Although the selection of experts was appropriate 
for the purpose of this study, the results may have 
limited generalisability.
 ► The importance attached to specific aspects of 
value- based health care may be subject to change, 
with some attaining relatively more or less impor-
tance depending on a particular timeframe.
 ► Experts could reformulate existing items and also 
suggest new ones; this enabled participants to 
express their personal (re)interpretation of value- 
based health care.
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(p5,99–105).4 Providers should thus realign their organ-
isational structures, forming integrated practice units 
which focus on one or a few related medical conditions 
and cover full care cycles (p167–77).4 Payment struc-
tures should also be aligned with value, with bundled 
payments for full cycles (or episodes) of care (p265–67).4 
Perhaps most importantly (according to these scholars), 
providers should actively engage in benchmarking: they 
should systematically measure, report and compare their 
outcome data. This would fuel value- based competition, 
and enable patients, payers, providers and policy- makers 
to all make more value- based decisions.4 In sum, VBHC 
encompasses numerous aspects and requires a whole 
range of actions and practices in order to be implemented.
In this paper, we aim to identify the relative importance 
of the various aspects of this multifaceted concept. This is 
both timely and important, because although the recent 
uptake of VBHC has been described as remarkable3; it 
nonetheless remains unclear what practical steps should 
be undertaken, and what aspects should be prioritised on 
the road towards a more value- based system. In fact, as 
mentioned earlier, several studies report muddled imple-
mentation efforts,9 11 and it also appears that scholars 
employ different standards when they discuss the imple-
mentation of VBHC (cf. 12–14). In addition, several 
scholars have stated that the way in which a multifaceted 
concept such as VBHC moves from idea to practice, is 
highly contingent on the particular intricacies within 
different health systems.11 15 Thus, uncertainty prevails 
when it comes to the actual implementation of VBHC.
In this paper, we build on the Delphi method to iden-
tify the relative importance of various actions and prac-
tices in moving towards a value- based system in the 
Netherlands. The Dutch healthcare system is a particu-
larly interesting case since it is based on regulated compe-
tition.16 Moreover, the measurement and use of outcome 
data are increasingly becoming an important issue in 
Dutch healthcare policy.16 Several of VBHC’s aspects (as 
outlined by Porter) are thus already in place.
Accordingly, our research question is: which aspects, 
actions and practices do Dutch experts agree on as 
important in moving towards a value- based healthcare 
system?
METHODS
The Delphi technique is a well- established research 
method to build consensus where considerable uncer-
tainty exists, and where empirical evidence is (still) 
lacking.17–20 In this modified Delphi study, we explore 
Dutch expert consensus on the most important aspects of 
VBHC, and the actions and practices that will contribute 
to implement VBHC in the Dutch system.
We recruited our expert panel through purposive 
sampling. Ten experts were selected based on their 
known or stated expertise regarding VBHC and the Dutch 
healthcare system. Nine panel members completed the 
first survey round: 4 females and 5 males who, at the time 
of the study, averaged nearly 23 years of experience in 
their current professional field, with 8 out of 9 members 
counting >10 years of experience regarding quality 
improvement. Additionally, these experts all have signifi-
cant experience working with VBHC inspired initiatives, 
either through their profession within a hospital (n=5) 
or through their collaboration with healthcare organisa-
tions (n=4). Of the five participants working in a hospital, 
two are professors at an academic hospital, with a back-
ground in medicine; two are project leaders (VBHC); one 
is a manager (quality). Of those not directly employed by 
healthcare providers, one has a managerial function at a 
hospital association; the remaining three work in health-
care consultancy.
We created an initial list of 39 items (available on 
request). The bulk of these items were derived from the 
pioneering literature on VBHC.4 6 21–24 We complemented 
this with several items that—particularly within Dutch 
health policy—are strongly related to VBHC. Accord-
ingly, these items were extracted from policy documents 
that directly deal with one or more aspects of VBHC (eg, 
outcome measurements).25–27 These complementary 
items are warranted, since our study builds on the notion 
that the implementation of VBHC will vary between 
health systems and sociopolitical regions.11 15 Examples of 
item descriptions are: ‘assessing the quality of a treatment 
cycle by measuring the achieved health status’; ‘creating 
integrated practice units (IPUs)’; and ‘learning from 
relating data on outcomes to data on costs of health care.’
Our expert panel completed questionnaires during 
a two- round modified Delphi survey, in which they 
rated each item according to ‘how important you deem 
this item in moving towards a value- based healthcare 
system?’ Scoring occurred on a four- point Likert scale: 
(1) ‘very important’, (2) ‘important’, (3) ‘moderately 
important’, (4) ‘not important’ (4). The first survey was 
sent out in December 2017, the second in January 2018. 
Panel members were given 3 weeks to complete each 
questionnaire.
In line with previous Delphi studies,28 we retained 
items after each round that were rated as ‘very important’ 
(1), or ‘important’ (2), by at least 80% of the experts, 
and excluded those rated as ‘not important’ (4), or 
only ‘moderately important’ (3), by more than 50% the 
experts. We expect the distribution of scores to be skewed 
towards agreement on importance. Therefore, our 
threshold for agreement on importance (≥80% scores 
very important or important) is higher than for agree-
ment on non- importance (>50%) scores moderately or 
not important.
Importantly, after rating an item, each expert was asked 
whether they had suggestions to reformulate that partic-
ular item. Additionally, by the end of the survey round, 
experts also had the possibility to add new items to the 
list, as they saw fit. Suggested additions and reformula-
tions would become part of the next survey round. The 
second survey round, therefore, consisted of both the 
reformulated and unchanged items that scored between 
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inclusion and exclusion, plus the newly suggested ones 
from round one.
We thus conducted a modified Delphi study, particularly 
because we did not enable experts to revisit the aggre-
gate scores of each item between survey rounds.18 Since 
our goal was to generate consensus, we decided that only 
those items on which no consensus was reached in the 
first round would be presented to the panel again in the 
second round.
Patient and public involvement statement
Within this study, there has been no involvement from 
patients or members of the public in the design, conduct, 
reporting or dissemination plans of the research.
RESULTS
Table 1 shows the flow of our Delphi study. Of the 10 
experts that were recruited, 9 (90%) agreed to partici-
pate and completed the study. Our analysis of the second 
round of questionnaires revealed missing data regarding 
one of the panel members; we therefore omitted this 
expert’s data for the entire second round (80% response 
rate).
As the table shows, 20 items were included in the first 
round, that is, rated as important (2) or very important 
(1) by at least 80% of the panel members. Additionally, 
six items were rated ‘moderately important’ (3) or ‘not 
important’ (4) by more than 50% of the experts and 
were therefore excluded. This entails that no consensus 
was reached on 13 of our initial 39 items. These items 
thus became part of the second round, as did 5 new items 
put forth by panel members. In the second survey round, 
another 12 items were included by the panel members, 
bringing the total number of included items to 32 
(20+12).
See table 2, for an overview of all 32 items that were 
included through expert consensus after 2 survey rounds. 
No consensus was reached on six items (see table 3 for an 
overview). However, in the second survey round experts 
did not suggest new items, nor did they suggest any refor-
mulations—thus indicating saturation was reached.
Table 2 shows the 32 items that are included based 
on their consensually perceived importance in moving 
towards a value- based healthcare system. The items are 
rank ordered, first by mean (x̄), second by SD (s). The 
mean (x̄) indicates the average score of the item (ie, its 
perceived importance) according to our panel (rated by 
each member on a 4- point scale). An item’s SD (s) was 
primarily used to rank order items with a similar mean, 
and can be regarded as a secondary indicator of overall 
agreement among panel members. The table also displays 
whether items were included in round 1 or 2.
According to experts, the most important practice in 
moving towards VBHC in the Netherlands is to involve 
patients in shared decision- making. Experts unanimously 
agree on the high importance of this item (#26). Other 
high ranking items on which experts agree are: to stan-
dardise performance measures for full treatment cycles 
of medical conditions (#21); to organise delivery of care 
around these full treatment cycles (#4); to use patient- 
reported outcome measures for evaluating care provision 
(#28); to use dashboards or scorecards to assess and visu-
alise performance (#34); to learn how to optimise the 
relationship between health outcomes and costs (#43); 
and to assess the quality of care based on the patients' 
recovery process after treatment(s) (#23).
After two rounds of questionnaires, six items remained 
on which no consensus could be reached. In other words, 
these items were neither rated (very) important by ≥80% 
of the experts, nor were they rated moderately or not 
important by ≥50%. These six items are shown in table 3.
Experts did not reach consensus on the idea that the 
payment of healthcare delivery should be based on actual 
costs, rather than predetermined price rates (#40). Our 
panel also could not agree on the importance of the 
continual revision and improvement of standardised 
measures (#37), and the same applies to the repeated 
revision of general protocols and regulations (#18). Addi-
tionally, no consensus was reached on the importance of 
benchmarking based on outcome data (#39). Disagree-
ment also remained regarding the issue of quality assess-
ment based on the sustainability of a patient’s health 
(#24). Similarly, experts did not agree on the importance 
of incentivising providers to improve their treatment 
outcomes (#31).
DISCUSSION
Our Delphi study identified expert consensus on the rela-
tive importance of aspects, actions and practices in moving 
towards a value- based healthcare system. Consensus was 
reached on 32 items that are deemed important (table 2). 
In round 2, no new items were put forth, and there were 
also no suggestions for reformulation, thus indicating that 
saturation was reached. In the second round, six items 
remained on which experts did not agree sufficiently for 
either inclusion or exclusion.
Table 1 Results survey rounds 1 and 2
Response Round 1 (90 %) Round 2 (80%)





Included 20 (45%) 12 (66.7%)
Excluded 6 (13.6%) 0 (0.00%)
Discordance: Discordance:
Reformulated 8 (18.2%) 0 (0.00%)
Unchanged 5 (11.4%) 6 (33.3%)
Newly suggested items: 5 (11.4%) 0 (0%)
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Our most eye- catching finding concerns the consensus 
on the importance of shared decision- making (SDM). 
Experts unanimously rated this particular item (#26) 
as ‘very important’ in moving towards a value- based 
system—which demonstrates a unique level of agree-
ment, unmatched by any other item in this study. Inter-
estingly, SDM is by no means a fundamental aspect within 
the pioneering literature on VBHC.4–6 22 In contrasts to 
SDM, which specifically concerns the deliberate discus-
sion of treatment options, this body of work emphasises 
the value- adding options patients have (or should have) 
in choosing among healthcare providers. Recently, it has 
been argued that the original VBHC concept, and the 
framework of market- based choices on which it rests, 
deemphasises patients’ personal values in life.3 Perhaps 
our panel’s unanimous agreement indicates that the 
incorporation of SDM may add a more personal dimen-
sion to VBHC—which has been advocated by some 
scholars.29
In addition, multiple items reveal that experts agree 
on the importance of recognising full care cycles for medical 
conditions as the relevant level of analysis in health care. 
This applies to the organisation of healthcare delivery 
(#4 and 17), its performance measurements (#21), and 
its payment structures (#30). This resonates with the liter-
ature on VBHC, particularly with the work of Porter, who 
repeatedly states that value in health care is created at the 
level of medical conditions, over full cycles of care.4 6 30
Several items on which consensus was reached relate 
to the importance of outcome information (eg, #22, 25, 
28). Our panel agreed, for instance, that it is important 
to assess the quality of a treatment cycle by measuring the 
achieved health status (ie, outcomes) of patients (#22). 
This overall emphasis on outcome measurement also 
corresponds with the literature.4 22 24
Regarding outcomes, this correspondence may seem 
relatively straightforward, since the central tenet of 
VBHC is that all stakeholders must aim to improve value 
for patients, with value defined as health outcomes per 
unit of costs.4 7 However, our panel did not display similar 
correspondence regarding costs—the denominator of 
value ( value =
outcomes
costs  ). Dutch experts thus appear to 
prioritise measuring outcomes over measuring costs, 
which may reflect other studies that indicate that when 
VBHC is being implemented, the costs of care attain rela-
tively little attention.8 31
One of the items on which our panel did not agree 
concerns the importance of comparing and bench-
marking provider’s performance data (#39). Accordingly, 
and strikingly, experts did not reach consensus regarding 
the importance of one of the most foundational aspects 
of VBHC theory:
Providers need to be compared on results, and ex-
cellent providers rewarded with more patients. 
Information about results [outcomes versus costs], 
which is appropriately risk adjusted, must become 
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referring physicians, by health plans, by patients, and 
by providers themselves.4 (p102)
Faced with the challenge to establish a value- based 
system in the Netherlands, it appears that although Dutch 
experts agree on the importance of multiple aspects of 
Porter’s original conceptualisation of VBHC, they also 
blend in additional concepts (eg, SDM), while bypassing 
others (eg, benchmarking). It will require additional 
research, however, to determine the extent to which our 
study represents the range of Dutch expert opinion on 
this issue.
Limitations
One potential limitation of this study is that our panel 
consisted entirely of Dutch experts. However, we were 
interested in the implementation of VBHC in the Dutch 
system, and it therefore made sense to invite Dutch 
experts to participate. Accordingly, this has enabled 
us to demonstrate how, in the Netherlands, VBHC is 
being adapted and blended with other concepts such 
as shared decision- making. Additionally, experts might 
have been influenced by the particular items that were 
first presented to them, and this could have affected their 
scoring. To counterbalance this potential bias, however, 
experts could reformulate existing items, while also being 
able to suggest new ones as they saw fit—both of which 
they did (see table 1).
CONCLUSION
In this paper, we identified expert consensus on the rela-
tive importance of a variety of concepts and practices for 
moving towards a value- based healthcare system. Accord-
ingly, our study provides additional insight regarding 
several important steps within the implementation 
of VBHC—a topical concern within many healthcare 
systems. However, our study also reveals considerable 
contrast with the pioneering literature on VBHC. Perhaps 
our results, based on a Dutch expert panel, are a precursor 
to a process of implementation of VBHC in the Nether-
lands that deviates from the original concept—which has 
been observed elsewhere.8 9 In such circumstances, some 
scholars have questioned whether VBHC is actually being 
implemented or, on closer look, primarily serves as an 
inspiring idea.31
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